NI (NATI) Tops Q4 EPS by 1c, Offers Guidance

NI (NASDAQ: NATI) reported Q4 EPS of $0.63, $0.01 better than the analyst estimate of $0.62. Revenue for the quarter came in at $448 million versus the consensus estimate of $452.81 million.

GUIDANCE:

NI sees Q1 2023 EPS of $0.48-$0.62, versus the consensus of $0.47. NI sees Q1 2023 revenue of $415-445 million, versus the consensus of $419.6 million.

For earnings history and earnings-related data on NI (NATI) click here.

You May Also Be Interested In

• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• Acurx Pharmaceuticals (ACXP) Tops Q2 EPS by 4c
• Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M